UBS Group AG - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,744,955
-53.4%
77,865
-15.4%
0.00%0.0%
Q2 2023$3,743,714
+0.6%
92,051
+19.8%
0.00%0.0%
Q1 2023$3,721,258
-10.4%
76,822
-29.4%
0.00%
-50.0%
Q4 2022$4,155,492
+169.1%
108,868
+253.9%
0.00%
+100.0%
Q3 2022$1,544,000
-33.3%
30,761
-46.8%
0.00%0.0%
Q2 2022$2,315,000
-56.3%
57,792
-59.3%
0.00%
-50.0%
Q1 2022$5,296,000
+2.6%
141,969
+9.5%
0.00%
+100.0%
Q4 2021$5,164,000
+120.9%
129,672
+106.4%
0.00%0.0%
Q3 2021$2,338,000
+58350.0%
62,822
+67450.5%
0.00%
Q2 2021$4,000
-99.7%
93
-99.7%
0.00%
-100.0%
Q1 2021$1,562,000
-25.1%
32,972
-3.5%
0.00%0.0%
Q4 2020$2,086,000
+14800.0%
34,184
+11527.2%
0.00%
Q3 2020$14,000
-94.6%
294
-94.2%
0.00%
Q2 2020$257,000
-92.0%
5,063
-93.0%
0.00%
-100.0%
Q1 2020$3,207,000
+15.6%
71,889
+24.5%
0.00%
+100.0%
Q4 2019$2,774,000
-5.3%
57,749
-33.3%
0.00%0.0%
Q3 2019$2,929,000
+602.4%
86,606
+834.6%
0.00%
Q2 2019$417,000
+24.9%
9,267
+4.6%
0.00%
Q1 2019$334,000
-88.3%
8,856
-89.4%
0.00%
-100.0%
Q4 2018$2,862,000
+102.3%
83,397
+177.1%
0.00%0.0%
Q3 2018$1,415,000
+249.4%
30,099
+150.6%
0.00%
Q2 2018$405,000
+45.2%
12,011
+16.6%
0.00%
Q1 2018$279,000
-78.0%
10,298
-86.4%
0.00%
-100.0%
Q4 2017$1,266,000
-0.7%
75,863
+19.1%
0.00%0.0%
Q3 2017$1,275,000
+153.5%
63,713
+132.2%
0.00%
Q2 2017$503,000
-72.1%
27,436
-85.0%
0.00%
-100.0%
Q1 2017$1,806,000
+2517.4%
183,513
+2792.2%
0.00%
Q4 2016$69,000
-46.1%
6,345
-30.4%
0.00%
Q3 2016$128,000
+113.3%
9,110
+6.9%
0.00%
Q2 2016$60,000
-79.7%
8,518
-81.5%
0.00%
Q1 2016$296,000
-97.2%
46,005
-85.7%
0.00%
-100.0%
Q4 2015$10,444,000
+3932.4%
322,331
+3223.0%
0.01%
Q3 2015$259,000
+475.6%
9,700
+941.9%
0.00%
Q2 2015$45,000
-87.5%
931
-84.2%
0.00%
Q1 2015$359,000
+372.4%
5,910
+303.4%
0.00%
Q4 2014$76,0001,4650.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders